Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.01.17	ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC (RTTNews)
19.01.17	Allergan Announces FDA Approval Of RHOFADE Cream (RTTNews)
19.01.17	Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults (PR Newswire)
18.01.17	Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks (RTTNews)
17.01.17	Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids (PR Newswire)
12.01.17	Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast (PR Newswire)
09.01.17	Allergan Purchases Option Right To Acquire Lysosomal Therapeutics - Quick Facts (RTTNews)
09.01.17	Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds (PR Newswire)
05.01.17	Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook (PR Newswire)
04.01.17	Allergan: FDA Accepts For Filing SNDA For Liletta (RTTNews)
04.01.17	FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg (PR Newswire)
04.01.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)
04.01.17	AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal (RTTNews)
03.01.17	EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN (PR Newswire)
03.01.17	Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants (PR Newswire)
24.12.16	Class Action Lawsuit Filed in the United States District Court for the District of New Jersey Against Allergan plc on Behalf of Shareholders - Lead Plaintiff Deadline Remains January 3, 2017 -- AGN (PR Newswire)
22.12.16	Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients (PR Newswire)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C (RTTNews)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2 (RTTNews)
21.12.16	Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference (PR Newswire)
21.12.16	AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date (RTTNews)
20.12.16	Allergan To Acquire LifeCell Corp Of Acelity For $2.9 Bln In Cash (RTTNews)
20.12.16	Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion (PR Newswire)
19.12.16	Salpeter Gitkin, LLP Informing Investors of Allergan plc of Securities Class Action Lawsuits (PR Newswire)
15.12.16	Allergan Announces Civil Resolution Concluding Federal Investigation into Forest Sales & Marketing Practices (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
09.12.16	Allergan Says Dissapointed In PTAB's Decision On RESTASIS Patents (RTTNews)
08.12.16	Allergan Comments on PTAB Decision Regarding Mylan's Petitions for Inter Partes Review (IPR) of RESTASIS® Patents (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
02.12.16	Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab (PR Newswire)
02.12.16	Allergan Provides Update on Accelerated Share Repurchase (ASR) Program (PR Newswire)
02.12.16	Allergan Announces Settlement Of Patent Litigation On DELZICOL (RTTNews)
02.12.16	Allergan Announces Settlement Of Patent Litigation On DELZICOL (RTTNews)
02.12.16	Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation (PR Newswire)
01.12.16	Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
23.11.16	Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN (PR Newswire)
22.11.16	Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease (PR Newswire)
22.11.16	Allergan Gets FDA Clearance For Xen Glaucoma Treatment (RTTNews)
22.11.16	Allergan Receives FDA Clearance for the XEN® Gel Stent, a New Surgical Treatment for Refractory Glaucoma (PR Newswire)
21.11.16	Allergan Reports Additional Approval From Health Canada For FIBRISTAL (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		GSK-Aktie verliert: GSK erreicht Fortschritte bei Eierstockkrebs-Therapie
20.12.24		Wechsel bei Sanofi: Ex-Morphosys-Chef Kress tritt in den Verwaltungsrat ein -Sanofi-Aktie tiefer
20.12.24		Anleger in Zürich halten sich zurück: SMI am Freitagmittag in Rot

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Handel in Zürich: SMI verbucht Verluste

20.12.24

GSK-Aktie verliert: GSK erreicht Fortschritte bei Eierstockkrebs-Therapie